Copyright
©The Author(s) 2020.
World J Gastroenterol. May 21, 2020; 26(19): 2416-2426
Published online May 21, 2020. doi: 10.3748/wjg.v26.i19.2416
Published online May 21, 2020. doi: 10.3748/wjg.v26.i19.2416
Table 3 Comparison between quartiles of baseline gamma-glutamyl transferase level and median 10-year cardiovascular disease risk according to QRISK2, median (interquartile range)
| Quartiles | Q1 | Q2 | Q3 | Q4 | P value |
| Patients, n = 1122 | 279 | 273 | 282 | 288 | |
| Median GGT (U/L) | 29 (23-33) | 48 (43-56) | 81 (71-89) | 151 (122-220) | |
| High CVD risk (%) | 84 (30.1) | 86 (31.5) | 61 (21.6) | 91 (31.6) | 0.025 |
| Median 10-year, CVD risk (%) | 6.1 (2.7-11.2) | 6.6 (2.9-11.9) | 4.7 (2.4-9.1) | 6.4 (2.6-12.9) | < 0.001 |
- Citation: Pitisuttithum P, Chan WK, Goh GBB, Fan JG, Song MJ, Charatcharoenwitthaya P, Duseja A, Dan YY, Imajo K, Nakajima A, Ho KY, Goh KL, Wong VWS, Treeprasertsuk S. Gamma-glutamyl transferase and cardiovascular risk in nonalcoholic fatty liver disease: The Gut and Obesity Asia initiative. World J Gastroenterol 2020; 26(19): 2416-2426
- URL: https://www.wjgnet.com/1007-9327/full/v26/i19/2416.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i19.2416